Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 173

1.

The Emperor's New Clothes: Prospective Observational Evaluation of the Association between Initial Vancomycin Exposure and Failure Rates among Adult Hospitalized Patients with MRSA Bloodstream Infections (PROVIDE).

Lodise TP, Rosenkranz SL, Finnemeyer M, Evans S, Sims M, Zervos MJ, Creech CB, Patel PC, Keefer M, Riska P, Silveira FP, Scheetz M, Wunderink RG, Rodriguez M, Schrank J, Bleasdale SC, Schultz S, Barron M, Stapleton A, Wray D, Chambers H, Fowler V, Holland TL; Antibacterial Resistance Leadership Group.

Clin Infect Dis. 2019 Jun 3. pii: ciz460. doi: 10.1093/cid/ciz460. [Epub ahead of print]

PMID:
31157370
2.

Impact of an antimicrobial stewardship intervention in India: Evaluation of post-prescription review and feedback as a method of promoting optimal antimicrobial use in the intensive care units of a tertiary-care hospital.

Rupali P, Palanikumar P, Shanthamurthy D, Peter JV, Kandasamy S, Zacchaeus NGP, Alexander H, Thangavelu P, Karthik R, Abraham OC, Michael JS, Paul H, Veeraraghavan B, Chacko B, Jeyaseelan V, Alangaden G, Prentiss T, Zervos MJ.

Infect Control Hosp Epidemiol. 2019 May;40(5):512-519. doi: 10.1017/ice.2019.29.

PMID:
31084674
3.

Impact of Reported β-Lactam Allergy on Management of Methicillin-Sensitive Staphylococcus aureus Bloodstream Infections.

Veve MP, January SE, Kenney RM, Zoratti EM, Zervos MJ, Davis SL.

J Pharm Pract. 2019 Apr 16:897190019841737. doi: 10.1177/0897190019841737. [Epub ahead of print]

PMID:
30991876
4.

Combatting resistant enterococcal infections: a pharmacotherapy review.

Mercuro NJ, Davis SL, Zervos MJ, Herc ES.

Expert Opin Pharmacother. 2018 Jun;19(9):979-992. doi: 10.1080/14656566.2018.1479397. Epub 2018 Jun 7. Review.

PMID:
29877755
5.

Environmental Panels as a Proxy for Nursing Facility Patients With Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus Colonization.

Cassone M, Mantey J, Perri MB, Gibson K, Lansing B, McNamara S, Patel PK, Cheng VCC, Walters MS, Stone ND, Zervos MJ, Mody L.

Clin Infect Dis. 2018 Aug 31;67(6):861-868. doi: 10.1093/cid/ciy115.

PMID:
29726892
6.

Presence of the esp gene in Enterococcus faecium derived from oropharyngeal microbiota of haematology patients.

Jovanović M, Tošić T, Jovanović S, Stošović R, Stevanović G, Velebit B, Zervos MJ.

Arch Oral Biol. 2018 Apr;88:54-59. doi: 10.1016/j.archoralbio.2018.01.008. Epub 2018 Jan 31.

PMID:
29407752
7.

The impact of obesity and timely antiviral administration on severe influenza outcomes among hospitalized adults.

Segaloff HE, Evans R, Arshad S, Zervos MJ, Archer C, Kaye KS, Martin ET.

J Med Virol. 2018 Feb;90(2):212-218. doi: 10.1002/jmv.24946. Epub 2017 Sep 25.

8.

In vivo study of Plasmodium falciparum chloroquine susceptibility in three departments of Haiti.

Raccurt CP, Brasseur P, Cicéron M, Parke DM, Zervos MJ, Boncy J.

Malar J. 2017 Aug 4;16(1):313. doi: 10.1186/s12936-017-1961-2.

9.

Multidrug-Resistant Microorganisms Colonizing Lower Extremity Wounds in Patients in a Tertiary Care Hospital, Lima, Peru.

Mendo-Lopez R, Jasso L, Guevara X, Astocondor AL, Alejos S, Bardossy AC, Prentiss T, Zervos MJ, Jacobs J, García C.

Am J Trop Med Hyg. 2017 Oct;97(4):1045-1048. doi: 10.4269/ajtmh.17-0235. Epub 2017 Jul 19.

10.

Risk Factors for 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.

Ayau P, Bardossy AC, Sanchez G, Ortiz R, Moreno D, Hartman P, Rizvi K, Prentiss TC, Perri MB, Mahan M, Huang V, Reyes K, Zervos MJ.

Int J Infect Dis. 2017 Aug;61:3-6. doi: 10.1016/j.ijid.2017.05.010. Epub 2017 May 19.

11.

The Safety and Economic Impact of Cefazolin versus Nafcillin for the Treatment of Methicillin-Susceptible Staphylococcus aureus Bloodstream Infections.

Flynt LK, Kenney RM, Zervos MJ, Davis SL.

Infect Dis Ther. 2017 Jun;6(2):225-231. doi: 10.1007/s40121-017-0148-z. Epub 2017 Mar 6.

12.

Ceftaroline fosamil monotherapy for methicillin-resistant Staphylococcus aureus bacteremia: a comparative clinical outcomes study.

Arshad S, Huang V, Hartman P, Perri MB, Moreno D, Zervos MJ.

Int J Infect Dis. 2017 Apr;57:27-31. doi: 10.1016/j.ijid.2017.01.019. Epub 2017 Jan 25.

13.

Impact and Limitations of the 2015 National Health and Safety Network Case Definition on Catheter-Associated Urinary Tract Infection Rates.

Bardossy AC, Jayaprakash R, Alangaden AC, Starr P, Abreu-Lanfranco O, Reyes K, Zervos MJ, Alangaden GJ.

Infect Control Hosp Epidemiol. 2017 Feb;38(2):239-241. doi: 10.1017/ice.2016.278. Epub 2016 Nov 24.

PMID:
27881213
14.

The Mental Health of Transgender Youth: Advances in Understanding.

Connolly MD, Zervos MJ, Barone CJ 2nd, Johnson CC, Joseph CL.

J Adolesc Health. 2016 Nov;59(5):489-495. doi: 10.1016/j.jadohealth.2016.06.012. Epub 2016 Aug 17. Review.

PMID:
27544457
15.

Safety and efficacy of outpatient parenteral antibiotic therapy in an academic infectious disease clinic.

Suleyman G, Kenney R, Zervos MJ, Weinmann A.

J Clin Pharm Ther. 2017 Feb;42(1):39-43. doi: 10.1111/jcpt.12465. Epub 2016 Oct 16.

PMID:
27747899
16.

False-positive cerebrospinal fluid cryptococcus antigen in Libman-Sacks endocarditis.

Isseh IN, Bourgi K, Nakhle A, Ali M, Zervos MJ.

Infection. 2016 Dec;44(6):803-805. Epub 2016 May 31.

PMID:
27246719
17.

Characterization of Salmonella Isangi possessing a CTX-M15 ESBL associated with an outbreak in a US Hospital.

Suleyman G, Perri M, Vager D, Samuel L, Zervos MJ, Alangaden G, Tibbetts RJ.

Diagn Microbiol Infect Dis. 2016 Jul;85(3):386-390. doi: 10.1016/j.diagmicrobio.2016.03.016. Epub 2016 Mar 29.

PMID:
27130476
18.

Nosocomial Outbreak of a Novel Extended-Spectrum β-Lactamase Salmonella enterica Serotype Isangi Among Surgical Patients.

Suleyman G, Tibbetts R, Perri MB, Vager D, Xin Y, Reyes K, Samuel L, Chami E, Starr P, Pietsch J, Zervos MJ, Alangaden G.

Infect Control Hosp Epidemiol. 2016 Aug;37(8):954-61. doi: 10.1017/ice.2016.85. Epub 2016 Apr 25.

PMID:
27108715
19.

Influence of Minimum Inhibitory Concentration in Clinical Outcomes of Enterococcus faecium Bacteremia Treated With Daptomycin: Is it Time to Change the Breakpoint?

Shukla BS, Shelburne S, Reyes K, Kamboj M, Lewis JD, Rincon SL, Reyes J, Carvajal LP, Panesso D, Sifri CD, Zervos MJ, Pamer EG, Tran TT, Adachi J, Munita JM, Hasbun R, Arias CA.

Clin Infect Dis. 2016 Jun 15;62(12):1514-1520. doi: 10.1093/cid/ciw173. Epub 2016 Apr 3.

20.

Pertussis: Microbiology, Disease, Treatment, and Prevention.

Kilgore PE, Salim AM, Zervos MJ, Schmitt HJ.

Clin Microbiol Rev. 2016 Jul;29(3):449-86. doi: 10.1128/CMR.00083-15. Review.

21.

Reply to "Urinary Tract Infections: Resistance Is Futile".

Kenney RM, Cole KA, Perri MB, Dumkow LE, Samuel LP, Zervos MJ, Davis SL.

Antimicrob Agents Chemother. 2016 Mar 25;60(4):2598. doi: 10.1128/AAC.00011-16. Print 2016 Apr. No abstract available.

22.

Safety and efficacy of commonly used antimicrobial agents in the treatment of enterococcal infections: a review.

Suleyman G, Zervos MJ.

Expert Opin Drug Saf. 2016;15(2):153-67. doi: 10.1517/14740338.2016.1127349. Epub 2015 Dec 23. Review.

PMID:
26629598
23.

Comparative Effectiveness of Vancomycin Versus Daptomycin for MRSA Bacteremia With Vancomycin MIC >1 mg/L: A Multicenter Evaluation.

Moise PA, Culshaw DL, Wong-Beringer A, Bensman J, Lamp KC, Smith WJ, Bauer K, Goff DA, Adamson R, Leuthner K, Virata MD, McKinnell JA, Chaudhry SB, Eskandarian R, Lodise T, Reyes K, Zervos MJ.

Clin Ther. 2016 Jan 1;38(1):16-30. doi: 10.1016/j.clinthera.2015.09.017. Epub 2015 Nov 14.

PMID:
26585355
24.

Outcomes of Aminopenicillin Therapy for Vancomycin-Resistant Enterococcal Urinary Tract Infections.

Cole KA, Kenney RM, Perri MB, Dumkow LE, Samuel LP, Zervos MJ, Davis SL.

Antimicrob Agents Chemother. 2015 Dec;59(12):7362-6. doi: 10.1128/AAC.01817-15. Epub 2015 Sep 14.

25.

Malaria elimination in Haiti by the year 2020: an achievable goal?

Boncy PJ, Adrien P, Lemoine JF, Existe A, Henry PJ, Raccurt C, Brasseur P, Fenelon N, Dame JB, Okech BA, Kaljee L, Baxa D, Prieur E, El Badry MA, Tagliamonte MS, Mulligan CJ, Carter TE, Beau de Rochars VM, Lutz C, Parke DM, Zervos MJ.

Malar J. 2015 Jun 5;14:237. doi: 10.1186/s12936-015-0753-9.

26.

Clinical Outcomes of Daptomycin for Vancomycin-resistant Enterococcus Bacteremia.

Moise PA, Sakoulas G, McKinnell JA, Lamp KC, DePestel DD, Yoon MJ, Reyes K, Zervos MJ.

Clin Ther. 2015 Jul 1;37(7):1443-1453.e2. doi: 10.1016/j.clinthera.2015.04.008. Epub 2015 May 15.

PMID:
25982687
27.

Evaluation of in vitro susceptibility trends to vancomycin and daptomycin by strain type of Staphylococcus aureus causing bloodstream infections.

Shoyinka A, Moreno D, Arshad S, Perri MB, Donabedian SM, Jacobsen G, Hartman P, Ziegler R, Huang V, Zervos MJ.

J Glob Antimicrob Resist. 2014 Dec;2(4):280-285. doi: 10.1016/j.jgar.2014.05.002. Epub 2014 Jun 7.

PMID:
27873688
28.

Prevalence of and risk factors for vancomycin-resistant Staphylococcus aureus precursor organisms in Southeastern Michigan.

Albrecht VS, Zervos MJ, Kaye KS, Tosh PK, Arshad S, Hayakawa K, Kallen AJ, McDougal LK, Limbago BM, Guh AY.

Infect Control Hosp Epidemiol. 2014 Dec;35(12):1531-4. doi: 10.1086/678605.

PMID:
25419776
29.

Comparative effectiveness of two catheter locking solutions to reduce catheter-related bloodstream infection in hemodialysis patients.

Moore CL, Besarab A, Ajluni M, Soi V, Peterson EL, Johnson LE, Zervos MJ, Adams E, Yee J.

Clin J Am Soc Nephrol. 2014 Jul;9(7):1232-9. doi: 10.2215/CJN.11291113. Epub 2014 Jun 26.

30.

Higher clinical success in patients with ventilator-associated pneumonia due to methicillin-resistant Staphylococcus aureus treated with linezolid compared with vancomycin: results from the IMPACT-HAP study.

Peyrani P, Wiemken TL, Kelley R, Zervos MJ, Kett DH, File TM Jr, Stein GE, Ford KD, Scerpella EG, Welch V, Ramirez JA; IMPACT-HAP Study Group.

Crit Care. 2014 Jun 10;18(3):R118. doi: 10.1186/cc13914.

31.

A novel treatment option for MRSA pneumonia: ceftaroline fosamil-yielding new hope in the fight against a persistent infection.

Arshad S, Hartman P, Zervos MJ.

Expert Rev Anti Infect Ther. 2014 Jul;12(7):727-9. doi: 10.1586/14787210.2014.908118. Epub 2014 Jun 5.

PMID:
24898885
32.

Major variation in MICs of tigecycline in Gram-negative bacilli as a function of testing method.

Marchaim D, Pogue JM, Tzuman O, Hayakawa K, Lephart PR, Salimnia H, Painter T, Zervos MJ, Johnson LE, Perri MB, Hartman P, Thyagarajan RV, Major S, Goodell M, Fakih MG, Washer LL, Newton DW, Malani AN, Wholehan JM, Mody L, Kaye KS.

J Clin Microbiol. 2014 May;52(5):1617-21. doi: 10.1128/JCM.00001-14. Epub 2014 Mar 5.

33.

Molecular characterization of vancomycin-resistant enterococci in Serbia: intensive care unit as the source.

Jovanović M, Milošević B, Dulović O, Pelemiš M, Stevanović G, Tošić T, Stošović B, Zervos MJ.

Acta Microbiol Immunol Hung. 2013 Dec;60(4):433-46. doi: 10.1556/AMicr.60.2013.4.5.

PMID:
24292087
34.

Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial.

Harris AD, Pineles L, Belton B, Johnson JK, Shardell M, Loeb M, Newhouse R, Dembry L, Braun B, Perencevich EN, Hall KK, Morgan DJ; Benefits of Universal Glove and Gown (BUGG) Investigators, Shahryar SK, Price CS, Gadbaw JJ, Drees M, Kett DH, Muñoz-Price LS, Jacob JT, Herwaldt LA, Sulis CA, Yokoe DS, Maragakis L, Lissauer ME, Zervos MJ, Warren DK, Carver RL, Anderson DJ, Calfee DP, Bowling JE, Safdar N.

JAMA. 2013 Oct 16;310(15):1571-80.

35.

Prevalence and risk factors associated with vancomycin-resistant Staphylococcus aureus precursor organism colonization among patients with chronic lower-extremity wounds in Southeastern Michigan.

Tosh PK, Agolory S, Strong BL, Verlee K, Finks J, Hayakawa K, Chopra T, Kaye KS, Gilpin N, Carpenter CF, Haque NZ, Lamarato LE, Zervos MJ, Albrecht VS, McAllister SK, Limbago B, Maccannell DR, McDougal LK, Kallen AJ, Guh AY.

Infect Control Hosp Epidemiol. 2013 Sep;34(9):954-60. doi: 10.1086/671735. Epub 2013 Jul 26.

36.

Review of three magnetic resonance arthrography related infections.

Vollman AT, Craig JG, Hulen R, Ahmed A, Zervos MJ, van Holsbeeck M.

World J Radiol. 2013 Feb 28;5(2):41-4. doi: 10.4329/wjr.v5.i2.41.

37.

Emergence of methicillin-resistant Staphylococcus aureus USA300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA.

Pasquale TR, Jabrocki B, Salstrom SJ, Wiemken TL, Peyrani P, Haque NZ, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, File TM Jr; IMPACT-HAP Study Group.

Int J Infect Dis. 2013 Jun;17(6):e398-403. doi: 10.1016/j.ijid.2012.12.013. Epub 2013 Feb 1.

38.

Analysis of pathogen and host factors related to clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus.

Haque NZ, Arshad S, Peyrani P, Ford KD, Perri MB, Jacobsen G, Reyes K, Scerpella EG, Ramirez JA, Zervos MJ.

J Clin Microbiol. 2012 May;50(5):1640-4. doi: 10.1128/JCM.06701-11. Epub 2012 Feb 15.

39.

Incidence of nephrotoxicity and association with vancomycin use in intensive care unit patients with pneumonia: retrospective analysis of the IMPACT-HAP Database.

Cano EL, Haque NZ, Welch VL, Cely CM, Peyrani P, Scerpella EG, Ford KD, Zervos MJ, Ramirez JA, Kett DH; Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Study Group.

Clin Ther. 2012 Jan;34(1):149-57. doi: 10.1016/j.clinthera.2011.12.013.

PMID:
22284995
40.

Epidemiology and outcomes of complicated skin and soft tissue infections in hospitalized patients.

Zervos MJ, Freeman K, Vo L, Haque N, Pokharna H, Raut M, Kim M.

J Clin Microbiol. 2012 Feb;50(2):238-45. doi: 10.1128/JCM.05817-11. Epub 2011 Nov 23.

41.

Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study.

Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ.

Clin Infect Dis. 2012 Jan 1;54(1):51-8. doi: 10.1093/cid/cir764. Epub 2011 Nov 21.

PMID:
22109947
42.

Severity of disease and clinical outcomes in patients with hospital-acquired pneumonia due to methicillin-resistant Staphylococcus aureus strains not influenced by the presence of the Panton-Valentine leukocidin gene.

Peyrani P, Allen M, Wiemken TL, Haque NZ, Zervos MJ, Ford KD, Scerpella EG, Mangino JE, Kett DH, Ramirez JA; IMPACT-HAP Study Group.

Clin Infect Dis. 2011 Oct;53(8):766-71. doi: 10.1093/cid/cir541. Epub 2011 Aug 31.

PMID:
21880581
43.

Prediction of failure in vancomycin-treated methicillin-resistant Staphylococcus aureus bloodstream infection: a clinically useful risk stratification tool.

Moore CL, Lu M, Cheema F, Osaki-Kiyan P, Perri MB, Donabedian S, Haque NZ, Zervos MJ.

Antimicrob Agents Chemother. 2011 Oct;55(10):4581-8. doi: 10.1128/AAC.00115-11. Epub 2011 Aug 8.

44.

Development and implementation of a performance improvement project in adult intensive care units: overview of the Improving Medicine Through Pathway Assessment of Critical Therapy in Hospital-Acquired Pneumonia (IMPACT-HAP) study.

Mangino JE, Peyrani P, Ford KD, Kett DH, Zervos MJ, Welch VL, Scerpella EG, Ramirez JA; IMPACT-HAP Study Group.

Crit Care. 2011;15(1):R38. doi: 10.1186/cc9988. Epub 2011 Jan 25.

45.

Implementation of guidelines for management of possible multidrug-resistant pneumonia in intensive care: an observational, multicentre cohort study.

Kett DH, Cano E, Quartin AA, Mangino JE, Zervos MJ, Peyrani P, Cely CM, Ford KD, Scerpella EG, Ramirez JA; Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators.

Lancet Infect Dis. 2011 Mar;11(3):181-9. doi: 10.1016/S1473-3099(10)70314-5. Epub 2011 Jan 20.

PMID:
21256086
46.

Human and swine hosts share vancomycin-resistant Enterococcus faecium CC17 and CC5 and Enterococcus faecalis CC2 clonal clusters harboring Tn1546 on indistinguishable plasmids.

Freitas AR, Coque TM, Novais C, Hammerum AM, Lester CH, Zervos MJ, Donabedian S, Jensen LB, Francia MV, Baquero F, Peixe L.

J Clin Microbiol. 2011 Mar;49(3):925-31. doi: 10.1128/JCM.01750-10. Epub 2011 Jan 12.

47.

Characterization of vancomycin-resistant Enterococcus faecium isolated from swine in three Michigan counties.

Donabedian SM, Perri MB, Abdujamilova N, Gordoncillo MJ, Naqvi A, Reyes KC, Zervos MJ, Bartlett P.

J Clin Microbiol. 2010 Nov;48(11):4156-60. doi: 10.1128/JCM.02346-09. Epub 2010 Aug 25.

48.

Dissemination of an Enterococcus Inc18-Like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus.

Zhu W, Murray PR, Huskins WC, Jernigan JA, McDonald LC, Clark NC, Anderson KF, McDougal LK, Hageman JC, Olsen-Rasmussen M, Frace M, Alangaden GJ, Chenoweth C, Zervos MJ, Robinson-Dunn B, Schreckenberger PC, Reller LB, Rudrik JT, Patel JB.

Antimicrob Agents Chemother. 2010 Oct;54(10):4314-20. doi: 10.1128/AAC.00185-10. Epub 2010 Jul 26.

49.

Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia.

Haque NZ, Zuniga LC, Peyrani P, Reyes K, Lamerato L, Moore CL, Patel S, Allen M, Peterson E, Wiemken T, Cano E, Mangino JE, Kett DH, Ramirez JA, Zervos MJ; Improving Medicine through Pathway Assessment of Critical Therapy of Hospital-Acquired Pneumonia (IMPACT-HAP) Investigators.

Chest. 2010 Dec;138(6):1356-62. doi: 10.1378/chest.09-2453. Epub 2010 Jun 17.

PMID:
20558550
50.

USA600 (ST45) methicillin-resistant Staphylococcus aureus bloodstream infections in urban Detroit.

Moore CL, Osaki-Kiyan P, Perri M, Donabedian S, Haque NZ, Chen A, Zervos MJ.

J Clin Microbiol. 2010 Jun;48(6):2307-10. doi: 10.1128/JCM.00409-10. Epub 2010 Mar 24. No abstract available.

Supplemental Content

Loading ...
Support Center